MetaVia
MTVA • XNAS
MetaVia is a pharmaceutical preparations company trading on XNAS, led by CEO Heon Kim Hyung, with a market cap of $6.2M.
CEOHeon Kim Hyung
Next Earnings
Upcoming earnings announcement for MetaVia
Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$1.99
Earnings History
Past 12 earnings reports for MetaVia
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | Q4 2025 | -$0.42Est: -$1.92 | +78.1% | - | — |  10-K |
| Nov 6, 2025 | Q3 2025 | -$0.14Est: -$0.25 | +44.0% | - | — | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.26Est: -$0.32 | +18.8% | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.36Est: -$0.65 | +44.6% | - | — | 10-Q |
| Mar 20, 2025 | Q4 2024 | -$0.32Est: -$0.89 | +64.0% | - | — | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.55Est: -$0.73 | +24.7% | - | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$1.85Est: -$1.12 | -65.2% | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$1.32Est: -$1.10 | -20.0% | - | — | 10-Q |
| Mar 28, 2024 | Q4 2023 | -$1.02Est: -$0.78 | -30.8% | - | — | 10-K |
| Nov 13, 2023 | Q3 2023 | -$0.72Est: -$0.88 | +18.2% | - | — | — |
| Aug 9, 2023 | Q2 2023 | -$0.16 | — | - | — | 10-Q |
| May 12, 2023 | Q1 2023 | -$0.48 | — | - | — | — |